Forbes Earnings Preview: Regeneron Pharmaceuticals

Leading up to Regeneron Pharmaceuticals (REGN) announcement of its first quarter earnings on Friday, May 3, 2013, analysts have become more bullish as expectations have improved over the past month from 95 cents per share to the current projection of earnings of $1.02 per share.